Cancer screening, diagnosis and mortality in Europe
Cancer is a major social issue in Western societies because of its high incidence and high mortality risk and particularly affects aging societies.. The good side of the coin is that cancer is in many cases avoidable, and early detection is key to increase the chance of cure. For that reason, many countries in Europe introduced organised screening programmes (OSP) for breast, cervical, and colorectal cancer. However, there are large regional differences across Europe as to whether and when OSPs were introduced. We exploit these variations in this project to comprehensively evaluate OSP.
The first OSPs in Europe date back to the 1980s and most of them are still active nowadays. However, after almost 40 years of implementation, a comprehensive evaluation of this policy is still missing. For instance, Do OSP have an impact on screening uptake? Do they reach the population at higher risk? Do OSP help increasing early diagnoses and reducing mortality? Do OSP impact inequality in healtcare use and health? This campus project aims is to fill this gap. This is a joint project with the Vienna University of Economics and Business.